Showing search results for `Sepsis`.
News [Showing 20 results of 39 found]:
- How AST Results Support Accurate Antibiotic Therapy in the Battle Against Bacterial Sepsis
- bioMérieux's AST System VITEK® REVEAL Achieves FDA 510(k) Clearance
- Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID 2024
- Q-linea Receives US FDA 510(k) Clearance for the ASTar® System
- Gradientech Signs Exclusive Contract with UK Distributor
- Labor Dr. Brunner Adopts QuantaMatrix dRAST Solution For Routine Clinical Use
- Gradientech’s Diagnostic System QuickMIC® Achieves CE-IVD Approval
- Evaluate the Entire Analytical Process of the BCID2 Panel Assay for Sepsis
- What's on Show at ECCMID 2022 - a rapidmicrobiology Special Focus
- Fast Forward to Actionable Results With Rapid AST
- FDA Clears SeptiCyte® RAPID - The First One-Hour, Direct-from-Blood Sepsis Test
- Rapid Identifier in Suspected Sepsis Cases Takes Just 30 Minutes for Result
- U.S. Patent Covers Gram-Positive and Gram-Negative Sepsis-Causing Bacteria - Looking for Partners
- First Diagnostic Test to Detect 13 AMR-Markers in 5 Hours Granted CE-IVD
- Next Generation Algorithim to Predict the Onset of Sepsis
- Selux Diagnostics 2nd Generation AST Gets Green Light
- CE Certification for DISQVER® - Automated Relevance-Based Detection of Blood Stream Infections
- EU Accelerates Approval of Bloodstream Infection Assay Kit
- T2Bacteria Panel - FDA Cleared Sepsis Test Now Available in More Markets
- CE Marked iC-GN Assay™ - ID and Resistance Markers from Positive Blood Cultures
Supplier [Showing 12 results of 12 found]:
- QuantaMatrix Inc.
- Immunexpress Inc.
- Noscendo GmbH
- Gradientech AB
- Global Sepsis Alliance
- T2 Biosystems
- Specific Technologies
- Primerdesign Ltd
- Momentum Bioscience
- Hycult Biotech
- DiaSorin Molecular LLC
- 3i Diagnostics